Vancouver, Canada – April 4, 2025 – AI/MLInnovations Inc. (“AIML” or the“Company”) (CSE: AIML;OTCQB: AIMLF; FWB: 42FB) is pleased to announce that it intends to complete a non-brokered private placement offering of up to 40,000,000 units (“Units”) at a price of $0.05 per Unit for gross proceeds of up to $2,000,000 (“Private Placement”).
Each Unit is comprised of one CommonShare and one warrant which will be exercisable into one
(1) Common Share of the Company (each a "Warrant"). Each Warrant will have a term of two (2) years and will entitle the holder to purchase one (1) Common Share at a price of $0.15 per Common Share following the closing date, subject to the Company’s right to accelerate expiry upon 30 days’ notice if the shares trade at $0.30 for a 10-day period. The Common Shares and Warrants comprising the Units will be subject to a four-month and one day hold period in accordance with the policies of the CSE and applicable securities legislation.
The Company intends to use net proceeds of the Private Placement for working capital requirements.
The Company will pay a finder's fee to qualified finders who assist in selling the Units, in cash or securities or a combination of both, as permitted by CSE policy and applicable securities laws.
The Private Placement is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including approval from the Canadian Securities Exchange.
For more information about AIML:
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.
For further information, contact: Blake Fallis at (778) 405-0882or info@aiml-innovations.com.
About AI/ML Innovations Inc. https://aiml-innovations.com/
AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its 100% owned Quantum Sciences Ltd., Neural Cloud Solutions Inc. and AI Rx Inc., its strategic partnership with Health Gauge Inc. (95.2% owned by AIML), and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AIML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".
On behalf of the Board of Directors:
Paul Duffy, ExecutiveChairman
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements – Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, including with respect to the completion of the Private Placement. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of AIML, including the timing and nature of all deliverables associated with the Private Placement and whether the Private Placement will be completed as currently proposed or at all. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
